Premier Alternatives

ShiraTronics

Minneapolis, MN · Founded 2018 · Privately Held (backing)

Developer of novel neuromodulation technologies designed to treat unmet neurology-based clinical needs. ShiraTronics is based in Minneapolis, MN and was founded in 2018. Its last known valuation is $142 million. It has raised $112 million across 2 recorded rounds; the latest was a $37.4 million early-stage round in Sep 2024.

Last price · $/share
—
Implied valuation
$142.0M
Total raised
$111.7M
Last round
Early Stage VC
Sep 2024

ShiraTronics key facts

  • Developer of novel neuromodulation technologies designed to treat unmet neurology-based clinical needs.
  • ShiraTronics’s last known valuation is $142.0M.
  • It has raised $111.7M across 2 recorded rounds; the latest was Early Stage VC ($37.4M) in Sep 2024.
  • Notable investors include Norwest, OSF Ventures, Amzak Health, Aperture Venture Partners, Breakout Ventures — 11 tracked in total.
  • ShiraTronics has filed 4 Form Ds with the SEC since 2019, most recently Sep 2024 ($37.4M sold to 30 investors).
  • Status: Privately Held (backing).
Free account
More of ShiraTronics with a free account
  • ·The complete investor list: 11 names
  • ·Watch ShiraTronics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

ShiraTronics funding rounds

2 rounds
Sep 2024Early Stage VC$37.4MSEC filing▮
Oct 2019Early Stage VC$41.7MSEC filing▮
Full funding history →

ShiraTronics valuation

ShiraTronics's last known valuation is $142 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has ShiraTronics raised?

ShiraTronics has raised $112 million in total; 2 of its rounds are on record. The largest on record was a $41.7 million early-stage round in Oct 2019; the most recent was a $37.4 million early-stage round in Sep 2024.

ShiraTronics has filed 4 Form Ds with the SEC since 2019, most recently in Sep 2024 ($37.4 million sold to 30 investors).

ShiraTronics investors

11 investors are on record for ShiraTronics, including Norwest, OSF Ventures, Amzak Health and Aperture Venture Partners. The early-stage round in Sep 2024 drew 30 investors.

About ShiraTronics

Developer of novel neuromodulation technologies designed to treat unmet neurology-based clinical needs. The company's technology offers continuous stimulation to targeted nerves associated with migraine, potentially relieving, interrupting, and preventing chronic migraine symptoms, enabling patients to combat debilitating migraine headaches effectively.

Sector
Healthcare
HQ
Minneapolis, MN, United States
Founded
2018
Employees
35
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$142.0M

ShiraTronics’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.